FDA allows expanded use of Takeda's Velcade

06/23/2008 | Bloomberg

Takeda Pharmaceutical Co. Ltd. has obtained FDA clearance to market Velcade -- acquired through its $8.8 billion takeover of Millennium Pharmaceuticals in May -- as an initial treatment for patients with multiple myeloma. The additional approval is based on study results showing that Velcade helped 35% of people newly diagnosed with the blood cancer experience remission.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC